Black Rock Inc. Arcturus Therapeutics Holdings Inc. Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,743,002 shares of ARCT stock, worth $106 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,743,002
Previous 2,398,296
14.37%
Holding current value
$106 Million
Previous $75.6 Million
22.5%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ARCT
# of Institutions
195Shares Held
26.7MCall Options Held
294KPut Options Held
318K-
Federated Hermes, Inc. Pittsburgh, PA4.7MShares$182 Million0.37% of portfolio
-
State Street Corp Boston, MA1.96MShares$76.1 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.69MShares$65.6 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$53.9 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.1.28MShares$49.5 Million0.43% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $1.03B
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...